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ABSTRACT: The physiological mechanisms controlling ovarian follicular growth and ovulation involve a complex exchange of
systemic signals and a localized exchange of molecules between the oocyte and surrounding somatic cells. It has been
demonstrated that the oocyte itself plays an essential role in regulating these processes by secreting two key regulatory proteins:
bone morphogenetic protein-15 (BMP15) and growth and differentiation factor-9 (GDF9). Natural mutations in their expression
and vaccination against these growth factors have been shown to cause sterility in sheep. The aim of this 3-year study was to
determine the effect of vaccination against GDF9 and BMP15 on fertility in female white-tailed deer. Does were randomly
assigned to two groups (n = 10/group). Each doe received a primary vaccination followed by a booster 47 days later. After the first
year, a subset of animals (n = 4-5/group) received an additional booster vaccination. Blood samples were collected at regular
intervals to determine antibody titers and progesterone concentrations. Early pregnancy was assessed by ultrasound, and fawning
was subsequently monitored. For the BMP15 group, over the 3 years 80%, 100%, and 75% of does fawned with fawning rates of
2.4, 3.5, and 3.3 fawns/doe, respectively. For the GDF9 group, 80%, 25%, and 25% of does fawned with fawning rates of 2.6, 1,
and 2 fawns/doe, respectively. The fawning rate of untreated animals in the herd was 1.8 fawns/doe. Although all animals in the
BMP15 group had high antibody titers, they were not made infertile, and they became more fecund. Most animals in the GDF9
group had high antibody titers, but fecundity was not affected the first year; however, they were made infertile in Years 2 and 3.
Results from this study demonstrate that vaccination against GDF9 has potential to control fertility in deer. Further research will be
required to determine the appropriate timing for administering the vaccine and the longevity of effect.
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INTRODUCTION
The white-tailed deer (Odocoileus virginianus) is
commonly found throughout North America. Locally
over-abundant populations are known to cause ecological
damage (Cote et al. 2004) and conflicts with human
activities (Conover 2002). The management of deer
populations is often carried out by lethal means, which in
more urban areas can be controversial. For many years,
fertility control using immunocontraceptive vaccines has
been investigated as a non-lethal tool to aid in these
efforts, with varying results (Cowan et al. 2003). The two
vaccines currently available target the reproductive
hormone gonadotropin-releasing hormone (GnRH) and
the zona pellucida, which is a glycoprotein coat that
surrounds the egg (oocyte). Vaccination against GnRH
suppresses the production of reproductive hormones,
including gonadal steroids, and behavioral estrus in
females, whereas vaccination against ZP prevents
fertilization. One of the challenges for the use of these
vaccines is maintaining an adequate immune response for
the reproductive life of the animal. This requires that
animals be re-vaccinated, sometimes annually, which is
difficult and costly. There is clearly a need to identify
new target molecules that can cause permanent sterility
without requiring that the immune response be
maintained for such an extended period.

The physiological mechanisms controlling ovarian
follicular growth and the number of oocytes released at
ovulation involve a complex exchange of systemic (e.g.,
endocrine) signals between various organs and the
ovaries, and a local exchange of molecules between the
oocyte and its surrounding somatic cells within the
ovaries (Matzuk et al. 2002, Gilchrist et al. 2004, Binelli
and Murphy 2010). Significant discoveries have shown
that the oocyte itself produces two key regulatory growth
factors, namely growth differentiation factor 9 (GDF9)
and bone morphogenetic factor 15 (BMP15), which are
essential for regulating follicular growth and ovulation
rate (Dong et al. 1996, Galloway et al. 2000). Both
GDF9 and BMP15 have been shown to be involved in
early follicular growth in several species (Bodensteiner et
al. 1999, Eckery et al. 2002, Juengel et al. 2004,
Shimasaki et al. 200, Juengel and McNatty 2005). In
sheep, it has been shown that animals that have a double
copy mutation in the genes encoding either GDF9 or
BMP15 are sterile but otherwise healthy. In these
animals, follicles do not progress beyond the first stage of
growth. Interestingly, in animals that have only a single
copy mutation in either of these genes, and thus produce
essentially only half the amount of protein, ovulation rate
is increased (Galloway et al. 2000, McNatty et al. 2005).
In mice, deletion of GDF9 leads to sterility, but if they
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don’t express BMP15 they are only sub-fertile and often
have decreased litter size (Moore and Shimasaki 2005).
Mutations in GDF9 or BMP15 have also been found in
women with premature ovarian failure (Pouresmaeili and
Fazeli 2014).
In a series of experiments conducted in sheep, it was
shown that ewes could be made infertile after immunization against either GDF9 or BMP15 (Juengel et al. 2002,
Juengle et al. 2004, McNatty et al. 2007). Moreover,
specific regions of each growth factor were identified that
were important for the biological activity of the respective
proteins. This enabled the production of effective peptide
vaccines that were specific to those regions.
The objective of this study was to determine the
effects of immunization against GDF9 and BMP15
peptides on ovarian function and fertility in female whitetailed deer. Our long-term goal is to develop a vaccine
that is better able to cause permanent sterility.
METHODS
Animals
White-tailed deer used in this study were maintained
at the Pennsylvania State University (PSU) Deer
Research Center, where a captive deer herd has been
maintained since 1972. During this study, the facility
encompassed 22 acres of natural woodland/forest habitat
which was divided into separate paddock areas.
Vegetation on the open areas consisted of a mixture of
clover and orchard grasses, but most of the land was
covered with dense deciduous forest that had little
understory vegetation. During the non-breeding portion
of the year, treated female deer were isolated from males.
However, to test vaccine contraceptive efficacy each year,
from the first week of November through the end of the
following February, bucks of proven sire ability were
introduced with the females.
Peptide Design
The peptides used to make the vaccines for this study
were chosen based on results from sheep studies
conducted by McNatty et al. (2007), which showed
immunization against these specific peptides inhibited
ovulation. The peptide sequences for both GDF9 and
BMP15 are located at the N-terminal regions of the
respective mature proteins. Using a basic local alignment
search tool (BLAST), we found that the respective
sequences in red deer are identical to those in sheep,
cattle, goats, mice, and hamsters. Therefore, we assumed
they would also be the same in white-tailed deer.
The peptides QAGSIASEVPGPSRGC (BMP15) and
HSEYFKQFLFPQNEC (GDF9) were synthesized by
Global Peptide (Fort Collins, CO). The underlined amino
acids represent the native peptide sequences. For the
BMP15 peptide, a glycine (G) residue was added at the
C-terminus as a spacer, followed by a cysteine (C) residue to aid coupling to the carrier protein. To make the
peptides immunogenic, they were coupled to a
maleamide-activated carrier protein, blue protein hemocyanin (Concholepas concholepas; Biosonda, Santiago,
Chile) as previously described (Miller et al. 2008). Each
1-ml dose of vaccine contained 1 mg of peptide-blue

protein conjugate in 0.5 ml of buffer emulsified with 0.5
ml of AdjuVac adjuvant (National Wildlife Research
Center, Fort Collins, CO).
Vaccination of Deer
Twenty sexually mature female white-tailed deer were
divided randomly into two groups (n = 10/group),
namely, BMP15 and GDF9. In July 2007, each deer
received a primary vaccination (1 ml) of the assigned
vaccine followed by a booster vaccination (1 ml) 47 days
later. A subset of animals from each group (BMP15 n =
4; GDF9 n = 4-5) received a second booster vaccination
at day 321. Vaccines were administered intramuscularly
in the hindquarter.
Blood samples were collected on days 0, 47, 96, 188,
554, 754, and 918. Approximately 7-10 ml of blood was
collected from the jugular vein at each time point.
Following collection, blood samples were centrifuged and
serum was isolated and stored at -70°C. Serum was used
to determine antibody titers and progesterone concentrations.
Laboratory Testing
Progesterone
The Coat-A-Count Progesterone In-vitro Diagnostic
Test Kit™ (Diagnostic Products, Los Angeles, CA) was
used to determine concentrations of progesterone in
serum samples according to the manufacturer’s recommended procedure.
Antibody Titers
Enzyme-linked immunosorbent assay (ELISA) was
used to determine anti-GDF9 and anti-BMP15 antibody
titers as previously described (Miller et al. 2008) with the
following modifications: plates were prepared by coating
each well overnight with 100 ng of GDF9-BSA or
BMP15-BSA. Titers were assigned as the highest dilution showing a significant absorbance value greater than
that of the corresponding pre-bleed value.
Assessment of Fertility
The mean reproductive success of the entire PSU
captive deer herd (1.8 fawns/doe) was used as a control
value that was compared with that of the deer vaccinated
against GDF9 and BMP15. The deer in the current study
were managed at the same facility and were maintained
under the same conditions. At the end of January in
2008, 2009, and 2010, ultrasound examinations were
performed to determine if does were pregnant. Ultimate
reproductive performance was assessed by evaluating
annual fawn production.
Statistical Analysis
Data for the number of fawns produced per doe were
analyzed by one-sample t-test comparing values to the
mean number of fawns produced (1.8) by the PSU deer
herd. Progesterone data for BMP15 animals was
analyzed by ANOVA. There was insufficient data to
analyze progesterone data for GDF9 animals. Statistical
analyses were performed using GraphPad Prism version
4.00 for Windows (GraphPad Software, San Diego, CA).
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RESULTS
Antibody Titers
Mean antibody titers for the two groups over the
course of the study are shown in Figure 1. All animals in
the BMP15 group developed high titers following the first
booster vaccination and maintained the high titers for the
duration of the study. Animals in the GDF9 group also
developed good titers, but they were more variable. One
doe in GDF9 group failed to mount an immune response
to the vaccine at any time during the study, and most of
the variability shown in the graph was due to this one
animal.

Figure 1. Mean antibody titers for BMP15 and GDF9
vaccinated animals. Days when the first and second
booster vaccinations were given are shown by B1 and B2,
respectively. The days when pregnancy was assessed by
ultrasound and progesterone measurements were made
are shown by a ‘U’. The breeding period for each year is
also shown.

Fertility
The results of ultrasound assessments, progesterone
concentrations, and number of fawns born are shown for
individual does in Tables 1 and 2. A progesterone
concentration of >1 ng/ml is indicative of an active
corpus luteum being present on the ovaries (Plotka et al.
1977, 1982). Mean progesterone concentrations did not
differ significantly between years for BMP15 animals.
Although not all does produced offspring in the first year,

based on progesterone measurements nearly all animals
were confirmed cycling and had active corpora lutea at
the time the blood sample was taken. In Years 2 and 3,
does in the BMP15 group continued to cycle and produce
offspring, but fertility of does in the GDF9 group was
inhibited. The doe in the GDF9 group that produced
offspring was the same doe that did not mount an
immune response to the vaccine. For the BMP15 group,
over the 3 years 80%, 100%, and 75% of does fawned
with fawning rates of 2.4, 3.5, and 3.3 fawns/doe,
respectively. For the GDF9 group, 80%, 25%, and 25%
of does fawned with fawning rates of 2.6, 1, and 2
fawns/doe, respectively. In Year 1, the number of fawns
per doe did not differ (P < 0.5) for either the BMP15 or
GDF9 groups compared to the control (1.8). In Years 2
and 3, does in the BMP15 group produced significantly
more fawns per doe. Apart from the one doe that did not
mount an immune response to GDF9, no other does in
this group produced fawns in Years 2 and 3.
DISCUSSION
Both BMP15 and GDF9 have been shown to be
essential for ovarian function in several species (Otsuka et
al. 2011). A major finding from this study is that both
BMP15 and GDF9 also have effects on ovarian function
and ovulation rate in white-tailed deer. Although the
antibody response to the BMP15 vaccine was very good
in all treated animals, vaccination against BMP15 caused
an increase in ovulation rate, resulting in an increased
number fawns per doe being produced. The reason for
this is unknown, but it may be that the antibodies
produced were only able to partially inactivate the
BMP15 protein in the ovaries, therefore causing a
phenotype similar to that found in sheep that are
heterozygous for a BMP15 mutation (Galloway et al.
2000). For the does vaccinated against GDF9, although
the increase was not significantly different from controls,
there seemed to be a trend towards an increase in the
number of fawns produced per doe in the first year.
Again, this may have been due to the antibodies only
being able to partially inactivate the GDF9 protein.
However, vaccination against GDF9 completely
suppressed fertility, and no fawns were born to does that
produced an antibody response in Years 2 and 3. Similar
effects have been demonstrated in sheep where

Table 1. Ultrasound results, progesterone (Prog) concentrations and number of fawns born for individual animals in the
BMP15 group. P = pregnant and NP = not pregnant; M = male and F = female.
BMP15

Year 1

Doe

Ultrasound

1
2
3
4
5
6
7
8
9
10

P
P
P
P
P
P
P
NP
P
P

Prog
(ng/ml)
5
13
8.9
11
6.7
6.2
7.6
5.7
10.5
8.2

Year 2
No. Fawns

Ultrasound

2M
1M/1F
1M/1F
5M
1M/2F
2M
1M
–
1M/1F
0

P
P
P
P
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Prog
(ng/ml)
7.3
15.7
6.6
10

Year 3
No. Fawns

Ultrasound

1M/3F
1M/2F
3F
2M/2F

P
P
P
P

Prog
(ng/ml)
5.8
16.7
6
5.6

No. Fawns
1M/2F
3M
0
3M/1F

Table 2. Ultrasound results, progesterone (Prog) concentrations and number of fawns born for individual animals in the
GDF9 group. P = pregnant and NP = not pregnant; M = male and F = female.
GDF9

Year 1

Doe

Ultrasound

1
2
3
4
5
6
7
8
9
10

P
P
NP
P
P
P
P
P
P
P

Prog
(ng/ml)
4.3
4.4
0.2
9.2
10.7
5.4
6.4
4.5
12.8
9.45

Year 2
No.
Fawns
1M
2M
–
2M/1F
2M
2M/1F
0
2M
3M/2F
3F

Prog
(ng/ml)
5.8
0.4
0.4
0.3
0.9

Ultrasound
P
NP
NP
NP
NP

immunization against BMP15 or GDF9 utilizing a ‘weak’
adjuvant caused an increase in ovulation rate, whereas
immunization against either growth factor utilizing a
‘strong’ adjuvant caused a decrease in ovulation and
inhibition of fertility (Juengel et al. 2004, McNatty et al.
2007).
Results from this study demonstrated that vaccination
against GDF9 has potential to control fertility in deer.
Further research will be required to determine the
appropriate timing for administering the vaccine,
improving the vaccine formulation and achieving the
desired longevity of effect.
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